Oxidative stress in metabolic dysfunction-associated steatohepatitis: Mechanisms and emerging therapeutic strategies
Biochemical Pharmacology · 2026-04 · 246 · 117702
DOI: 10.1016/j.bcp.2026.117702 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Pharmacology, 2026-04. Verfasst von Yidan Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jiangsu University, Zhenjiang 212013, China. Hauptthemen laut MEDLINE: Oxidative Stress, Fatty Liver, Metabolic Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 159 Literaturangaben. Gefördert von: Natural Science Research of Jiangsu Higher Education Institutions of China, Natural Science Foundation of Jiangsu Province, National Key Research and Development Program of China.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), affect a substantial proportion of the global population and have emerged as a major disease burden. If left untreated, MASH can progress to cirrhosis and hepatocellular carcinoma. However, effective pharmacological therapies for MASH remain limited. Accumulating evidence indicates that oxidative stress plays an important role in MASH pathogenesis by coordinating inflammatory responses and contributing to hepatocyte injury. Although previous studies have emphasized the importance of oxidative stress, a panoramic view of how oxidative stress emerges during the onset of MASH and sustains a vicious cycle of progression is still lacking. This review systematically discusses the mechanisms underlying oxidative stress-driven MASH progression, highlighting its interactions with inflammation, hepatocyte apoptosis, necroptosis, emerging ferroptosis, and mitochondria-associated membranes. Furthermore, we summarize the recent advances in investigational drugs targeting oxidative stress, encompassing key druggable targets as well as representative synthetic compounds, natural products, and biotechnology drugs. Collectively, this review aims to deepen the mechanistic understanding of oxidative stress in MASH and to provide insights into potential therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, Jiangsu University, Zhenjiang 212013, China.
- School of Pharmacy, Jiangsu University, Zhenjiang 212013, China. Electronic address: caizhang@ujs.edu.cn.
Förderung
- Natural Science Research of Jiangsu Higher Education Institutions of China
- Natural Science Foundation of Jiangsu Province
- National Key Research and Development Program of China
- Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions
Zitieren
APA
Chen, Y., Yu, H., Kai, X., Yin, R., Ouyang, Z., Wei, Y., & Zhang, C. (2026). Oxidative stress in metabolic dysfunction-associated steatohepatitis: Mechanisms and emerging therapeutic strategies. Biochemical Pharmacology, 246, 117702. https://doi.org/10.1016/j.bcp.2026.117702
Vancouver
Chen Y, Yu H, Kai X, Yin R, Ouyang Z, Wei Y, et al. Oxidative stress in metabolic dysfunction-associated steatohepatitis: Mechanisms and emerging therapeutic strategies. Biochemical Pharmacology. 2026;246:117702. doi:10.1016/j.bcp.2026.117702
BibTeX
@article{Chen2026,
author = {Chen, Yidan and Yu, Hui and Kai, Xinyu and Yin, Runting and Ouyang, Zhen and Wei, Yuan and Zhang, Cai},
title = {Oxidative stress in metabolic dysfunction-associated steatohepatitis: Mechanisms and emerging therapeutic strategies},
journal = {Biochemical Pharmacology},
year = {2026},
volume = {246},
pages = {117702},
doi = {10.1016/j.bcp.2026.117702}
}
EUVIMED